SOLARIS (Alliance A021703), a multicenter, double-blind, randomized Phase III clinical trial led by Dana-Farber Cancer ...

Discover the SOLARIS trial findings on high-dose Vitamin D3 for metastatic colorectal cancer. Learn about its impact on ...

A double-blind randomized clinical trial shows that high-dose vitamin D3 doesn't improve metastatic colorectal cancer ...

A team of US-based researchers has concluded that high-dose vitamin D3 does not provide any additional benefit for patients ...

However, study results suggest higher doses may benefit patients with tumors on the left side of the colon or rectum.

Study Title: SOLARIS (Alliance A021703): A multicenter double-blind phase III randomized clinical trial of vitamin D combined ...

A potential benefit for high-dose vitamin D3 was observed for patients with left-sided disease (i.e., primary tumors that arise in the descending colon, sigmoid colon, or rectum) and requires ...

A team of US researchers on Sunday said that high-dose vitamin D3 does not provide benefit for patients suffering from metastatic colorectal cancer. A randomised phase 3 clinical trial led by ...